Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype

Annals of the Rheumatic Diseases

Volumn 73, Issue 8, 2014, Pages 1585-1589

  Van Bon, L ^a,b   Cossu, M ^a,b   Loof, A ^b   Gohar, F ^c   Wittkowski, H ^c   Vonk, M ^b   Roth, J ^d   Van Den Berg, W ^b   Van Heerde, W ^b   Broen, J C A ^a   Radstake, T R D J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN A; CALGRANULIN B; PROTEOME; TOLL LIKE RECEPTOR AGONIST;

ADULT; ARTICLE; BLOOD ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS; DONOR; FEMALE; HUMAN; HUMAN CELL; LIMITED CUTANEOUS SYSTEMIC SCLEROSIS; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SKIN DISEASE; SUPERNATANT; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SYSTEMIC SCLEROSIS;

PROTEOMICS; S100A PROTEINS; SYSTEMIC SCLEROSIS; TOLL-LIKE RECEPTORS;

ADULT; AGED; BIOLOGICAL MARKERS; CALGRANULIN A; CALGRANULIN B; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDIES; PROTEOMICS; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TOLL-LIKE RECEPTORS;

EID: 84903878618     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-205013     Document Type: Article

References (25)

1. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5. (Pubitemid 18073738)
2. Beirne P, Pantelidis P, Charles P, et al. Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis. Eur Respir J 2009;34:1376-82.
3. Masi A, Subcommitte for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Critera commimittee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
4. Goh NS, Desai SR, Veeraraghavan S, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008;177:1248-54. (Pubitemid 351860934)
5. Opstal-van Winden AW, Beijnen JH, Loof A, et al. Search for breast cancer biomarkers in fractionated serum samples by protein profiling with SELDI-TOF MS. J Clin Lab Anal 2012;26:1-9.
6. van Bon L, Affandi AJ, Broen J, et al. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med 2014;370:433-43.
7. Rammes A, Roth J, Goebeler M, et al. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997;272:9496-502. (Pubitemid 27154966)
8. Roth J, Teigelkamp S, Wilke M, et al. Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology 1992;186:304-14.
9. van den Bos C, Rammes A, Vogl T, et al. Copurification of P6, MRP8, and MRP14 from human granulocytes and separation of individual proteins. Protein Expr Purif 1998;13:313-18. (Pubitemid 28378824)
10. Reich M, Liefeld T, Gould J, et al. GenePattern 2.0. Nat Genet 2006;38:500-1.
11. Wilkins MR, Gasteiger E, Tonella L, et al. Protein identification with N and C-terminal sequence tags in proteome projects. J Mol Biol 1998;278:599-608. (Pubitemid 28224857)
12. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
13. Frosch M, Ahlmann M, Vogl T, et al. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2009;60:883-91.
14. Holzinger D, Nippe N, Vogl T, et al. Myeloid-related proteins 8 and 14 contribute to monosodium urate crystal-induced inflammation in gout. Arthritis Rheumatol (Hoboken, NJ) 2014. doi:10.1002/art.38369 [Epub ahead of print]
15. Bhattacharyya S, Fang F, Tourtellotte W, et al. Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis). J Pathol 2013;229:286-97.
16. van Bon L, Popa C, Huijbens R, et al. Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 2010;69:1539-47.
17. He Z, Zhu Y, Jiang H. Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study. Respir Res 2009;10:126.
18. He Z, Gao Y, Deng Y, et al. Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway. PLoS One 2012;7:e35926.
19. Xu X, Wu WY, Tu WZ, et al. Increased expression of S100A8 and S100A9 in patients with diffuse cutaneous systemic sclerosis. A correlation with organ involvement and immunological abnormalities. Clin Rheumatol 2013;32: 1501-10.
20. Kuruto R, Nozawa R, Takeishi K, et al. Myeloid calcium binding proteins: expression in the differentiated HL-60 cells and detection in sera of patients with connective tissue diseases. J Biochem 1990;108:650-3. (Pubitemid 20336682)
21. Andreasson K, Scheja A, Saxne T, et al. Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis. J Intern Med 2011;270:50-7.
22. Hesselstrand R, Wildt M, Bozovic G, et al. Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis. Respir Med 2013;107:1079-86.
23. Yoshizaki A, Yanaba K, Ogawa A, et al. Immunization with DNA topoisomerase I and Freund's complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling. Arthritis Rheum 2011;63:3575-85.
24. Lood C, Stenstrom M, Tyden H, et al. Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus. Arthritis Res Ther 2011;13:R60.
25. Eloranta ML, Franck-Larsson K, Lovgren T, et al. Type I interferon system activation and association with disease manifestations in systemic sclerosis. Ann Rheum Dis 2010;69:1396-402.